Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 26,566 |
| Marketable Securities | 0 | 0 | 0 | 70,179 |
| Receivables | 0 | 0 | 0 | 4,448 |
| Inventories | 0 | 0 | 0 | 1,245 |
| Other current assets | 0 | 0 | 0 | 1,183 |
| TOTAL | $0 | $0 | $0 | $103,621 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 0 | 0 | 0 | 221 |
| TOTAL | $N/A | $N/A | $N/A | $221 |
| Total Assets | $0 | $0 | $0 | $110,040 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,166 |
| Accrued Expenses | 0 | 0 | 0 | 8,128 |
| Other current liabilities | 0 | 0 | 0 | 87 |
| TOTAL | $0 | $0 | $0 | $10,605 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 299,286 |
| TOTAL | $N/A | $N/A | $N/A | $299,541 |
| Total Liabilities | $0 | $0 | $0 | $313,145 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 0 | 1 |
| Retained earnings | 0 | 0 | 0 | -229,664 |
| Other shareholders' equity | 0 | 0 | 0 | 137 |
| TOTAL | $0 | $0 | $0 | $-203,105 |
| Total Liabilities And Equity | $0 | $0 | $0 | $110,040 |